TTK inhibition radiosensitizes basal-like breast cancer through impaired homologous recombination.
Chandler BC, Moubadder L, Ritter CL, Liu M, Cameron M, Wilder-Romans K, Zhang A, Pesch AM, Michmerhuizen AR, Hirsh N, Androsiglio M, Ward T, Olsen E, Niknafs YS, Merajver S, Thomas DG, Brown PH, Lawrence TS, Nyati S, Pierce LJ, Chinnaiyan A, Speers C.
Chandler BC, et al. Among authors: olsen e.
J Clin Invest. 2020 Feb 3;130(2):958-973. doi: 10.1172/JCI130435.
J Clin Invest. 2020.
PMID: 31961339
Free PMC article.